TNSN98124A1 - Compositions de sertraline solubilisee - Google Patents
Compositions de sertraline solubiliseeInfo
- Publication number
- TNSN98124A1 TNSN98124A1 TNTNSN98124A TNSN98124A TNSN98124A1 TN SN98124 A1 TNSN98124 A1 TN SN98124A1 TN TNSN98124 A TNTNSN98124 A TN TNSN98124A TN SN98124 A TNSN98124 A TN SN98124A TN SN98124 A1 TNSN98124 A1 TN SN98124A1
- Authority
- TN
- Tunisia
- Prior art keywords
- sertraline
- compositions
- solubilized
- solubilized sertraline
- sertraline compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
L'INVENTION CONCERNE UNE COMPOSITION COMPRENANT DE DE LA SERTRALINE ET UN AGENT SOLUBILISANT, PERMETTANT D'ATTEINDRE UNE PLUS FORTE CONCENTRATION DE SERTRALINE DISSOUTE DANS UN ENVIRONNEMENT D'UTILISATION. ELLE CONCERNE EGALEMENT UN PROCEDE POUR ACCROITRE LA SOLUBILITE DE LA SERTRALINE ET UN PROCEDE DE PREPARATION D'UNE FORME POSOLOGIQUE DE SERTRALINE A SOLUBILITE ACCRUE. APPLICATION : UTILISATION POUR LE TRAITEMENT D'UNE MALADIE PSYCHIATRIQUE OU D'AUTRES MALADIES
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5141397P | 1997-07-01 | 1997-07-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN98124A1 true TNSN98124A1 (fr) | 2005-03-15 |
Family
ID=21971159
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNTNSN98124A TNSN98124A1 (fr) | 1997-07-01 | 1998-06-30 | Compositions de sertraline solubilisee |
Country Status (34)
Country | Link |
---|---|
EP (1) | EP0999829A1 (fr) |
JP (1) | JP2000514100A (fr) |
KR (1) | KR100366373B1 (fr) |
CN (1) | CN1261794A (fr) |
AP (1) | AP1192A (fr) |
AR (3) | AR015917A1 (fr) |
AU (1) | AU742535B2 (fr) |
BG (1) | BG103918A (fr) |
BR (1) | BR9810739A (fr) |
CA (1) | CA2290974C (fr) |
CO (1) | CO4940495A1 (fr) |
DZ (1) | DZ2548A1 (fr) |
EA (1) | EA002481B1 (fr) |
HN (1) | HN1998000102A (fr) |
HR (1) | HRP980377A2 (fr) |
HU (1) | HUP0002236A3 (fr) |
ID (1) | ID23429A (fr) |
IL (1) | IL133076A (fr) |
IS (1) | IS5260A (fr) |
MA (1) | MA24587A1 (fr) |
NO (1) | NO996520L (fr) |
OA (1) | OA11243A (fr) |
PA (1) | PA8454301A1 (fr) |
PE (1) | PE97199A1 (fr) |
PL (1) | PL337804A1 (fr) |
SK (1) | SK181099A3 (fr) |
TN (1) | TNSN98124A1 (fr) |
TR (1) | TR199903297T2 (fr) |
TW (1) | TW550087B (fr) |
UA (1) | UA67741C2 (fr) |
UY (1) | UY25071A1 (fr) |
WO (1) | WO1999001120A1 (fr) |
YU (1) | YU68299A (fr) |
ZA (1) | ZA985708B (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1738749A1 (fr) | 1999-12-23 | 2007-01-03 | Pfizer Products Inc. | Compositions pharmaceutiques fournissant des concentrations de medicaments ameliorées |
US20030086972A1 (en) * | 2000-08-09 | 2003-05-08 | Appel Leah E. | Hydrogel-driven drug dosage form |
AP2001002264A0 (en) | 2000-08-30 | 2001-09-30 | Pfizer Prod Inc | Sustained release formulations for growth hormone secretagogues. |
US20040191207A1 (en) * | 2003-03-31 | 2004-09-30 | Lipari John M. | Alpha-hydroxy acid ester drug delivery compositions and methods of use |
ES2439582T3 (es) * | 2007-03-12 | 2014-01-23 | Dsm Ip Assets B.V. | Composiciones cosméticas |
TW201129557A (en) * | 2009-12-29 | 2011-09-01 | Kowa Co | Pharmaceutical composition for oral administration |
JPWO2011081117A1 (ja) * | 2009-12-29 | 2013-05-09 | 興和株式会社 | 経口投与用固形医薬組成物 |
CN109908354A (zh) * | 2017-12-12 | 2019-06-21 | 万特制药(海南)有限公司 | 盐酸舍曲林口服浓缩液及其制备工艺 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4803076A (en) * | 1986-09-04 | 1989-02-07 | Pfizer Inc. | Controlled release device for an active substance |
EP0415612B1 (fr) * | 1989-08-30 | 1993-11-10 | Pfizer Inc. | Utilisation de la sertraline pour le traitement des dépendances aux produits chimiques |
ZA97976B (en) * | 1996-04-05 | 1997-08-18 | Alza Corp | Uniform drug delivery theraphy. |
-
1998
- 1998-06-15 EA EA199900962A patent/EA002481B1/ru unknown
- 1998-06-15 CA CA002290974A patent/CA2290974C/fr not_active Expired - Fee Related
- 1998-06-15 IL IL13307698A patent/IL133076A/xx not_active IP Right Cessation
- 1998-06-15 PL PL98337804A patent/PL337804A1/xx unknown
- 1998-06-15 TR TR1999/03297T patent/TR199903297T2/xx unknown
- 1998-06-15 CN CN98806763A patent/CN1261794A/zh active Pending
- 1998-06-15 UA UA99116391A patent/UA67741C2/uk unknown
- 1998-06-15 KR KR10-1999-7011361A patent/KR100366373B1/ko not_active IP Right Cessation
- 1998-06-15 BR BR9810739-9A patent/BR9810739A/pt not_active Application Discontinuation
- 1998-06-15 AU AU75448/98A patent/AU742535B2/en not_active Ceased
- 1998-06-15 WO PCT/IB1998/000933 patent/WO1999001120A1/fr not_active Application Discontinuation
- 1998-06-15 YU YU68299A patent/YU68299A/sh unknown
- 1998-06-15 EP EP98923019A patent/EP0999829A1/fr not_active Withdrawn
- 1998-06-15 JP JP11506774A patent/JP2000514100A/ja active Pending
- 1998-06-15 HU HU0002236A patent/HUP0002236A3/hu unknown
- 1998-06-15 SK SK1810-99A patent/SK181099A3/sk unknown
- 1998-06-15 ID IDW991701A patent/ID23429A/id unknown
- 1998-06-25 TW TW087110267A patent/TW550087B/zh active
- 1998-06-25 AP APAP/P/1998/001280A patent/AP1192A/en active
- 1998-06-26 PE PE1998000573A patent/PE97199A1/es not_active Application Discontinuation
- 1998-06-29 PA PA19988454301A patent/PA8454301A1/es unknown
- 1998-06-29 AR ARP980103146A patent/AR015917A1/es not_active Application Discontinuation
- 1998-06-29 UY UY25071A patent/UY25071A1/es not_active IP Right Cessation
- 1998-06-30 DZ DZ980158A patent/DZ2548A1/fr active
- 1998-06-30 TN TNTNSN98124A patent/TNSN98124A1/fr unknown
- 1998-06-30 ZA ZA9805708A patent/ZA985708B/xx unknown
- 1998-06-30 MA MA25146A patent/MA24587A1/fr unknown
- 1998-07-01 HR HR60/051,413A patent/HRP980377A2/hr not_active Application Discontinuation
- 1998-07-01 HN HN1998000102A patent/HN1998000102A/es unknown
- 1998-07-01 CO CO98037137A patent/CO4940495A1/es unknown
-
1999
- 1999-11-19 IS IS5260A patent/IS5260A/is unknown
- 1999-11-23 BG BG103918A patent/BG103918A/xx unknown
- 1999-12-21 OA OA9900301A patent/OA11243A/en unknown
- 1999-12-28 NO NO996520A patent/NO996520L/no not_active Application Discontinuation
-
2003
- 2003-06-19 AR ARP030102180A patent/AR040280A2/es unknown
- 2003-06-19 AR ARP030102179A patent/AR040279A2/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN98019A1 (fr) | Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
TNSN99203A1 (fr) | Compositions pharmaceutiques pour le traitement de la migraine, et procede pour leur preparation | |
TNSN98017A1 (fr) | Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
TNSN00036A1 (fr) | Acides oxamiques nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
TNSN00252A1 (fr) | Compositions pharmaceutiques engendrant des concentrations accrues de medicaments | |
TNSN98025A1 (fr) | Derives d'acide arylsulfonylhydroxamique, procede pour leur preparation et compositions les contenant. | |
TNSN99053A1 (fr) | Hydroxamides d'acides (4-arylsulfonylamino)-tetrahydro- pyranne-4-carboxyliques), procede pour leur preparation et compositions les contenant | |
TNSN97078A1 (fr) | Derives d'indole nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant | |
TNSN99170A1 (fr) | Derives de tetrahydroquinoleine substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN00071A1 (fr) | Composition pharmaceutique comprenant un inhibiteur de cyp2d6 et un medicament a metabolisme catalyse par cyp2d6 | |
CA2330500A1 (fr) | Compositions pharmaceutiques gelifiables | |
TNSN99162A1 (fr) | Derives de quinoleine-2-one a substituant alcynyle nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN01017A1 (fr) | Compositions comprenant un antibiotique azalide, et procedes pour leur preparation | |
TNSN98082A1 (fr) | DERIVES SUBSTITUES EN C - 4 DE 9 - DESOXO - 9a - aza - 9a HOMOERYTHROMYCINE A. | |
TNSN98022A1 (fr) | DERIVES DE N-HYDROXY-β-SULFONYLPROPIONAMIDE, PROCEDE POUR LEUR PREPARATION ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT. | |
TNSN99171A1 (fr) | 4-carboxyamino-2-substitue-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN98150A1 (fr) | Derives d'acides aryloxyarylsulfonylaminohydroxamiques ; procede pour leur preparation et compositions pharmaceutiques les contenant | |
BE1002249A4 (fr) | Compositions pharmaceutiques. | |
TNSN99055A1 (fr) | Derives bicycliques d'acide hydroxamique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN99126A1 (fr) | Pyrrolopyrimidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN99156A1 (fr) | Derives d'acide hydroxypipecolate-hydroxamique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN99073A1 (fr) | Pyrazolopyrimidinones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN01173A1 (fr) | Compositions pharmaceutiques comprenant un antagoniste des recepteurs de nmda. | |
TNSN99110A1 (fr) | Inhibiteurs non peptidiques de l'adhesion cellulaire sous la dependance de vla-4, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN98084A1 (fr) | Derives de macrolides substitues en position c-4 |